Literature DB >> 3918267

The quality of life of patients with end-stage renal disease.

R W Evans, D L Manninen, L P Garrison, L G Hart, C R Blagg, R A Gutman, A R Hull, E G Lowrie.   

Abstract

We assessed the quality of life of 859 patients undergoing dialysis or transplantation, with the goal of ascertaining whether objective and subjective measures of the quality of life were influenced by case mix or treatment. We found that 79.1 per cent of the transplant recipients were able to function at nearly normal levels, as compared with between 47.5 and 59.1 per cent of the patients treated with dialysis (depending on the type). Nearly 75 per cent of the transplant recipients were able to work, as compared with between 24.7 and 59.3 per cent of the patients undergoing dialysis. On three subjective measures (life satisfaction, well-being, and psychological affect) transplant recipients had a higher quality of life than patients on dialysis. Among the patients treated with dialysis, those undergoing treatment at home had the highest quality of life. All quality-of-life differences were found to persist even after the patient case mix had been controlled statistically. Finally, the quality of life of transplant recipients compared well with that of the general population, but despite favorable subjective assessments, patients undergoing dialysis did not work or function at the same level as people in the general population.

Entities:  

Mesh:

Year:  1985        PMID: 3918267     DOI: 10.1056/NEJM198502283120905

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  188 in total

1.  [Changes in the quality of life after organ transplantations].

Authors:  M Niechzial; T Grobe; H Dörning; H Raspe; E Nagel
Journal:  Soz Praventivmed       Date:  1999

2.  Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse?

Authors:  A M Epstein; J Z Ayanian; J H Keogh; S J Noonan; N Armistead; P D Cleary; J S Weissman; J A David-Kasdan; D Carlson; J Fuller; D Marsh; R M Conti
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

3.  Assessment of quality of life in a single centre dialysis population using the KDQOL-SF questionnaire.

Authors:  P Carmichael; J Popoola; I John; P E Stevens; A R Carmichael
Journal:  Qual Life Res       Date:  2000-03       Impact factor: 4.147

4.  The SF36 as an outcome measure of services for end stage renal failure.

Authors:  J P Wight; L Edwards; J Brazier; S Walters; J N Payne; C B Brown
Journal:  Qual Health Care       Date:  1998-12

5.  Home haemodialysis in Ireland.

Authors:  D M Connaughton; A Jamal; J McWilliams; P O'Kelly; J Ormond; A Butler; N McEntee; E Tierney; G Lambe; M Denton; C Magee; P J Conlon
Journal:  Ir J Med Sci       Date:  2012-06-03       Impact factor: 1.568

6.  The social and emotional impact of cardiac transplantation.

Authors:  B M Jones; V P Chang; D W Baron
Journal:  Tex Heart Inst J       Date:  1986-03

Review 7.  Emerging indications for the use of cyclosporin in organ transplantation and autoimmunity.

Authors:  P A Keown
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

Review 8.  Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.

Authors:  Melissa Young; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

9.  Impact of modality choice on rates of hospitalization in patients eligible for both peritoneal dialysis and hemodialysis.

Authors:  Robert R Quinn; Pietro Ravani; Xin Zhang; Amit X Garg; Peter G Blake; Peter C Austin; James M Zacharias; John F Johnson; Sanjay Pandeya; Mauro Verrelli; Matthew J Oliver
Journal:  Perit Dial Int       Date:  2014 Jan-Feb       Impact factor: 1.756

Review 10.  Assessing and improving the health-related quality of life of patients with ESRD.

Authors:  Fredric O Finkelstein; Kelli L Arsenault; Ana Taveras; Kwabena Awuah; Susan H Finkelstein
Journal:  Nat Rev Nephrol       Date:  2012-10-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.